SEC 13F Intelligence

Nordea Investment Management AB / ELV

Nordea Investment Management AB’s Elevance Health Inc Formerly Position

Does Nordea Investment Management AB own Elevance Health Inc Formerly (ELV)? Yes — 141.6K shares worth $41M (+0.04% of its 13F portfolio) as of Q1 2026, down from 340.3K shares the prior filed quarter.

Position Value
$41M
Q1 2026
Shares
141.6K
% of Portfolio
+0.04%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $1.3BQ4 ’18Q1 ’19: $715MQ2 ’19: $650MQ3 ’19: $579MQ4 ’19: $721MQ4 ’19Q1 ’20: $546MQ2 ’20: $1.2BQ3 ’20: $607MQ4 ’20: $663MQ4 ’20Q1 ’21: $776MQ2 ’21: $804MQ3 ’21: $817MQ4 ’21: $989MQ4 ’21Q1 ’22: $983MQ2 ’22: $830MQ3 ’22: $749MQ4 ’22: $797MQ4 ’22Q1 ’23: $731MQ2 ’23: $718MQ3 ’23: $719MQ4 ’23: $768MQ4 ’23Q1 ’24: $779MQ2 ’24: $722MQ3 ’24: $640MQ4 ’24: $439MQ4 ’24Q1 ’25: $468MQ2 ’25: $308MQ3 ’25: $131MQ4 ’25: $119MQ4 ’25Q1 ’26: $41Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026141.6K$41M+0.04%
Q4 2025340.3K$119M+0.10%
Q3 2025408.8K$131M+0.11%
Q2 2025795.1K$308M+0.29%
Q1 20251.07M$468M+0.49%
Q4 20241.18M$439M+0.46%
Q3 20241.23M$640M+0.73%
Q2 20241.34M$722M+0.85%
Q1 20241.50M$779M+0.92%
Q4 20231.63M$768M+0.98%
Q3 20231.62M$719M+1.00%
Q2 20231.64M$718M+0.98%
Q1 20231.59M$731M+1.07%
Q4 20221.56M$797M+1.24%
Q3 20221.61M$749M+1.21%
Q2 20221.71M$830M+1.23%
Q1 20221.97M$983M+1.23%
Q4 20212.12M$989M+1.18%
Q3 20212.10M$817M+1.06%
Q2 20212.10M$804M+1.08%
Q1 20212.15M$776M+1.13%
Q4 20202.07M$663M+1.07%
Q3 20202.27M$607M+1.14%
Q2 20204.61M$1.2B+1.23%
Q1 20202.40M$546M+1.31%
Q4 20192.37M$721M+1.44%
Q3 20192.43M$579M+1.26%
Q2 20192.30M$650M+1.45%
Q1 20192.49M$715M+1.49%
Q4 20185.08M$1.3B+1.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nordea Investment Management AB’s full portfolio or all institutional holders of ELV.